Google DeepMind CEO Demis Hassabis says AI breakthroughs in biology research could be a $100B+ business, commercialized via DeepMind spinout Isomorphic Labs — First AI-designed drugs may be ready for testing in “next couple of years,” Google's AI boss Demis Hassabis tells Bloomberg Television
Posted from: this blog via Microsoft Power Automate.
